Canada· CA-DIN-02329271
OCTREOSCAN
A indium (111in) pentetreotide product containing indium in 111 chloride + pentetreotide, registered in Canada by CURIUM CANADA INC. The same ATC class is registered in 7 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Indium (111in) pentetreotide is registered in 7 of 19 countries.
Countries holding a registration under ATC V09IB01 (indium (111in) pentetreotide), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 3 of them publish a price we can compare per daily dose
Indium (111in) pentetreotide · ATC V09IB01
7 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Netherlands
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- INDIUM IN 111 CHLORIDE + PENTETREOTIDE
- Manufacturer
- CURIUM CANADA INC
- Country
- Canada (CA)
- ATC code
- V09IB01
- ATC class
- Indium (111In) pentetreotide
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Indium (111in) pentetreotide in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Czechia · Octreoscan
- Luxembourg · Octreoscan
- Netherlands · Octreoscan
- Portugal · Octreoscan (Nº De Catálogo Curium Netherlands : Drn 4920)
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1475d2e6-788e-4fc8-90a0-817b687b2cdb GET /v1/drugs/1475d2e6-788e-4fc8-90a0-817b687b2cdb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02329271",
"form": "SOLUTION",
"class": "Radiopharmaceutical",
"routes": [
"INTRAVENOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "V09IB01",
"schedule": [
"Schedule C"
],
"drug_code": "81497",
"strengths": [
"111 MBq",
"10 MCG"
],
"ahfs_class": null,
"substances": [
"INDIUM IN 111 CHLORIDE",
"PENTETREOTIDE"
],
"product_categorization": null
}See everything about indium (111in) pentetreotide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.